Loading...
XNZE
CVT
Market cap24mUSD
Nov 13, Last price  
0.60NZD
Name

Comvita Ltd

Chart & performance

D1W1MN
XNZE:CVT chart
P/E
5.60
P/S
0.20
EPS
0.11
Div yield, %
1.67%
Shrs. gr., 5y
2.15%
Rev. gr., 5y
2.12%
Revenues
213m
+10.67%
31,313,00039,295,00072,226,00084,934,00081,427,00094,917,000102,186,000113,668,000150,759,000181,276,000152,548,000176,698,000169,303,000195,280,000191,734,000209,093,000234,195,000200,683,000192,428,000212,964,000
Net income
8m
P
1,597,0001,525,000761,0004,959,000503,0008,224,0007,384,0007,795,00010,542,00015,423,6009,822,0008,211,000-27,717,000-9,701,0009,479,00012,784,00011,062,000-77,388,000-104,759,0007,743,000
CFO
35m
+2.82%
169,000-6,110,000847,00020,090,000-3,009,00012,547,0002,970,0008,521,00011,970,000-31,617,000-10,722,000-22,118,00021,873,00039,297,00024,825,0002,830,0002,398,0005,333,00034,136,00035,100,000
Dividend
Apr 03, 20240.0117647 NZD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Comvita Limited, along with its associated entities, specializes in the global production and distribution of natural health products. The company boasts a significant international presence, operating across diverse markets in Australasia, Asia (including China), North America, Europe, the Middle East, and Africa. Its extensive product portfolio features flagship items such as Manuka honey, propolis, and olive leaf extract. Additionally, it offers a wide array of medihoney, skincare, gourmet honey, elixirs, lozenges, and cider vinegar formulations, as well as dedicated solutions for oral and children's health. Comvita's range is meticulously designed to address diverse wellness needs, including supporting digestive health, soothing eczema-prone skin, boosting energy levels, promoting cardiovascular well-being, and fortifying immune support. The company also provides essential solutions for summer and travel requirements. Beyond product development, Comvita maintains a vertically integrated operational model, encompassing the ownership and management of apiaries (beekeeping operations), property assets, and valuable intellectual property. Established in 1974, Comvita Limited is headquartered in Te Puke, New Zealand.

Key people

Karl Gradon
Chief Executive Officer · since 2025
Brett Hewlett
Acting Chief Executive Officer · since 2024
Nigel Greenwood
Chief Financial Officer · since 2020
Mandy Tomkins-Dancey
Chief Financial Officer · since 2025
Ben Duncan
Interim Chief Operating Officer · since 2025
Monica Yianakis
Chief Digital and Marketing Officer · since 2024
Jackie Evans
Chief Science Officer · since 2020
Maria Cowdrey
Executive Assistant · since 2025
Nikki Leske
Head of People and Technology · since 2025
Erin Swanson
Head of Sustainability and Strategic Projects · since 2025
Wu Yawen
Non-Executive Director · since 2021
Bridget Coates
Independent Non-Executive Chairman of the Board · since 2024
Lucas Bunt
Non-Executive Independent Director · since 2024
Robert Major
Non-Executive Independent Director · since 2019
Michael Sang
Non-Executive Independent Director · since 2023
IPO date
Nov 14, 2003
Employees
511
Domiciled in
NZ
Incorporated in
NZ

Valuation

Title
NZD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT